Background
In the USA, between 7 and 16% of the students use stimulants in a non-medical way. In European countries, data on this phenomenon are scarce. Yet, apart from the question of unfair competition during the exams, the misuse of prescription stimulants can also have detrimental health effects. Methods In Flanders, a large-scale repeated quantitative survey among university and college students was performed. This survey started in 2005 in the Antwerp students. In 2009, a follow-up was done, also including the Ghent students. In March 2013, a third wave of the survey was performed, covering almost all Flemish students (n = 210,000). Questions were asked on the prevalence and frequency of licit and illicit drug use, negative consequences, mental health and context of substance use. In the third wave, a module has been included more specifically on attitudes toward stimulant use during the examination period. Results In total, 18,000 students filled out the questionnaire in 2009. Ever use of stimulants was 6.9%, past year use was 4.3%. The ever use in males was twice as high (9.6%) compared to females (4.8%). The same held for the past year use: 6.2% and 2.9%, respectively. Only one out of nine students who used in the past year, used these stimulants on a daily basis. Unlike the prevalence and frequency of alcohol use and illicit drug use, the use of prescription stimulants in university and college students was much higher during the examination periods compared to the academic year and the holidays. Of the past year stimulant users, almost 80% used stimulants at least weekly and 52.7% used daily during the examination period (compared to 13.6% and 20.0% of daily users during holidays and academic year, respectively). Extrapolations to the total group of Antwerp and Ghent students, indicate that about 3,000 students use stimulants on a daily basis during the examination period. Conclusions A substantial part of Flemish university and college students uses stimulant medication as a 'learning pill'. Monitoring this phenomenon is important to develop the appropriate prevention and information campaigns. During the EPH-conference, the third wave results will be presented.
Key messages
A substantial part of Flemish students uses prescription stimulants as a 'learning pill'.
To develop appropriate prevention and information campaigns, quality research data are needed. Two-thirds (65%, n = 322) were deaths from external causes while 35% (n = 174) were from diseaserelated causes. The four causes which accounted for the greatest number of deaths were accidental poisoning/overdose (n = 165), suicide (n = 108), mental and behavioural disorders (n = 49) and circulatory system diseases (n = 45).
Conclusions
Our findings highlighted the occurrence of death at an early age among illicit drug users. Preventive measures aimed at the leading causes of death will be beneficial in reducing premature deaths. Key messages A 14-year retrospective cohort study identified 496 deaths among 4817 treatment-seeking illicit drug users in Finland via linkage to the national death register. The mean age at death was 33.8 years.
Most deaths (65%) were from external causes and 35% were from disease-related causes. Accidental overdose, suicide, mental/behavioural disorders and circulatory diseases accounted for the most deaths. 
Findings
Data covering all 27 EU Member states are entered into an iterative model which appears appropriate. Issues are, however, identified with lack of transparency in the methodological details raising concerns about the quality of the data inputs to the model (for example interview data fail to account for legal cross border sales; illicit estimates rely heavily on tobacco industry empty pack surveys which may overestimate illicit due to their urban bias). The main concern was an overreliance on data supplied by PMI with inadequate external validation. Eg PMI sales data are validated using PMI prevalence data, yet PMI is unable to provide sales (shipment) data for strategic EU islands that historically played a key role in the illicit tobacco trade and its prevalence estimates differ grossly from independent data. These concerns are in turn reflected in the illicit measurements which, comparison with independent data suggests, exaggerate levels of illicit particularly in countries where cross border shopping is common (Austria, Finland, France) 
Background
In countries where prevalence of smoking is higher among the worse-off, tobacco consumption contributes to socioeconomic (SE) inequalities in health. Southern European countries, however, have traditionally been characterized by a higher prevalence of smoking among high SE groups. We investigated whether this traditional pattern still applied to Portugal by describing the evolution of SE inequalities in smoking between 1987 and 2006. Methods We used data from the 4 National Health Interview Surveys (NHIS) carried out so far in Portugal (1987 Portugal ( , 1995 Portugal ( , 1998 Portugal ( /99, 2005 . Our sample was restricted to people aged 25-79 (N = 135,796) . SE status was measured by educational level (in ISCED groups) and income (in quintiles). SE inequalities were measured through odds ratios from logistic regressions on the probability of being current smoker or having stopped smoking, adjusting for sex and age. Analyzes were performed separately for men and women. Background Symptoms of depression may be an independent contributor to continued smoking during and after pregnancy. Depressed persons may smoke in order to immediately ameliorate their sense of well-being or as a quick reward, which makes it harder for them to quit smoking compared to non-depressed persons. We want to obtain insight into the associations between smoking patterns and depressive feelings during pregnancy and postpartum, taking into account several socio-demographic characteristics. Methods An observational, prospective, non-interventional study was performed. Data of 605 women were collected between September 2008 and December 2010 at <16 weeks (T0) and between 32-34 weeks pregnancy (T1) and after 6 weeks postpartum (T2) on the participants' smoking behavior and of their partners, feelings of depression using the Beck Depression Inventory (BDI) and socio-demographic variables (age, educational level, marital status, gravidity, smoking behavior of the partner). Results We found significant higher BDI-scores in smokers and initial smokers (F(4,486) = 12.06; p < 0.001), low educated women (F(1,496) = 40.39; p < 0.0001), women without a job (F(1,489) = 6.14; p = 0.0136), pregnant women (F(2, 643) = 40.15; p < 0.0001), women with a smoking partner (F(1, 495) = 5.37; p < 0.021) and women younger than 29 years (F(1, 495) = 7.11; p < 0.0079). The relationship over time between BDI-score and smoking patterns, taking into account socio-demographic variables, was examined with mixed linear models. Lower educated smokers reported significant more feelings of depression during and after pregnancy compared to smokers with a higher education (F(8,619) = 2.29; p = .02). Conclusions Paying attention to depressive symptoms and offering adapted stop-smoking advice, especially to lower educated women and their smoking partners, might reduce the prevalence of smoking during and after pregnancy.
Key messages
Recent ex-smokers reported less symptoms of depression compared to (initial) smokers, suggesting that smoking cessation does not aggravate depressive symptoms during and after pregnancy. Smoking cessation might be hampered by depressive symptoms and thus interventions that also treat depression may facilitate smoking cessation.
